Drs. Ben Solomon, Leora Horn, & Jack West consider how valuable testing for PD-L1 expression is in clinical practice and whether it should be integrated in clinical decision making around immunotherapies.
Dr. Ben Levy discusses two trials that are trying to determine if immunotherapy can help lung cancer patients with earlier stage disease. Click here for information about the PACIFIC trial. The lung cancer vaccine trial will begin in early 2016.
Dr. Ben Levy discusses two trials that are trying to determine if immunotherapy can help lung cancer patients with earlier stage disease. Click here for information about the PACIFIC trial. The lung cancer vaccine trial will begin in early 2016.
Dr. Nathan Pennell discusses ALCHEMIST, an NCI-sponsored clinical trial looking at whether targeted post-op (adjuvant) therapy for patients with a driver mutation such as EGFR mutation or ALK rearrangement improves survival.
Dr. Nathan Pennell discusses ALCHEMIST, an NCI-sponsored clinical trial looking at whether targeted post-op (adjuvant) therapy for patients with a driver mutation such as EGFR mutation or ALK rearrangement improves survival.
I have started Tagrisso on Mar. 8 2018, 80mg for 64 days and 40mg for 365 days, After these days my PET/CT scan has shown progression of 10mm GGO at...
Hi, Question: Does anyone know of emerging research or clinical trials being done with ARID1A mutation for lung cancer here in US? History: I am stage...
In my continual education, I learned that the measure of PD-1 is an indication of likelihood of effectiveness of immunotherapy. The anecdotal belief...
Diagnosed with colon cancer Nov. 2016. Excellent response to chemo, radiation with no signs of tumor remaining. Opted to have colon resection, which...
Hi, I am in the uk and due to have to stop my pembro next week, not my choice but they will only let me have 35 cycles( 2 years) i was wondering if...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.